B. Riley Securities Upgrades Vaxart to Buy, Announces $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities analyst Mayank Mamtani has upgraded Vaxart (NASDAQ:VXRT) from Neutral to Buy and set a price target of $2.
January 31, 2024 | 2:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vaxart's stock rating has been upgraded by B. Riley Securities from Neutral to Buy with a price target of $2.
Analyst upgrades typically lead to a positive short-term reaction in the stock market as they suggest improved prospects for the company. The new price target of $2 indicates a potential upside from the current trading price, which may attract investors and drive up the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100